Sabourin Jessica, Bartoli Fiona, Antigny Fabrice, Gomez Ana Maria, Benitah Jean-Pierre
From the UMR S1180, INSERM, Université Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France and
From the UMR S1180, INSERM, Université Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France and.
J Biol Chem. 2016 Jun 17;291(25):13394-409. doi: 10.1074/jbc.M115.693911. Epub 2016 Apr 22.
Store-operated Ca(2+) entry (SOCE) has emerged as an important mechanism in cardiac pathology. However, the signals that up-regulate SOCE in the heart remain unexplored. Clinical trials have emphasized the beneficial role of mineralocorticoid receptor (MR) signaling blockade in heart failure and associated arrhythmias. Accumulated evidence suggests that the mineralocorticoid hormone aldosterone, through activation of its receptor, MR, might be a key regulator of Ca(2+) influx in cardiomyocytes. We thus assessed whether and how SOCE involving transient receptor potential canonical (TRPC) and Orai1 channels are regulated by aldosterone/MR in neonatal rat ventricular cardiomyocytes. Molecular screening using qRT-PCR and Western blotting demonstrated that aldosterone treatment for 24 h specifically increased the mRNA and/or protein levels of Orai1, TRPC1, -C4, -C5, and stromal interaction molecule 1 through MR activation. These effects were correlated with a specific enhancement of SOCE activities sensitive to store-operated channel inhibitors (SKF-96365 and BTP2) and to a potent Orai1 blocker (S66) and were prevented by TRPC1, -C4, and Orai1 dominant negative mutants or TRPC5 siRNA. A mechanistic approach showed that up-regulation of serum- and glucocorticoid-regulated kinase 1 mRNA expression by aldosterone is involved in enhanced SOCE. Functionally, 24-h aldosterone-enhanced SOCE is associated with increased diastolic [Ca(2+)]i, which is blunted by store-operated channel inhibitors. Our study provides the first evidence that aldosterone promotes TRPC1-, -C4-, -C5-, and Orai1-mediated SOCE in cardiomyocytes through an MR and serum- and glucocorticoid-regulated kinase 1 pathway.
储存性钙内流(SOCE)已成为心脏病理学中的一种重要机制。然而,心脏中上调SOCE的信号仍未被探索。临床试验强调了盐皮质激素受体(MR)信号通路阻断在心力衰竭及相关心律失常中的有益作用。越来越多的证据表明,盐皮质激素醛固酮通过激活其受体MR,可能是心肌细胞钙内流的关键调节因子。因此,我们评估了在新生大鼠心室肌细胞中,涉及瞬时受体电位阳离子通道亚家族C成员1(TRPC)和Orai1通道的SOCE是否以及如何受到醛固酮/MR的调节。使用定量逆转录聚合酶链反应(qRT-PCR)和蛋白质免疫印迹法进行分子筛选表明,醛固酮处理24小时通过激活MR特异性增加了Orai1、TRPC1、-C4、-C5和基质相互作用分子1的mRNA和/或蛋白质水平。这些效应与对储存性钙通道抑制剂(SKF-96365和BTP2)和强效Orai1阻滞剂(S66)敏感的SOCE活性的特异性增强相关,并被TRPC1、-C4和Orai1显性负性突变体或TRPC5小干扰RNA(siRNA)所阻断。一种机制研究方法表明,醛固酮对血清和糖皮质激素调节激酶1 mRNA表达的上调参与了增强的SOCE。在功能上,醛固酮处理24小时增强的SOCE与舒张期胞内钙离子浓度([Ca(2+)]i)升高有关,而储存性钙通道抑制剂可使其减弱。我们的研究首次证明,醛固酮通过MR和血清及糖皮质激素调节激酶1途径促进心肌细胞中TRPC1、-C4、-C5和Orai1介导的SOCE。